Allot SVP Grossman sells 5,000 shares at $7.37

Allot Ltd. Senior Vice President of R&D, Boaz Grossman, reported an open-market sale of 5,000 ordinary shares at $7.37 per share.

Rhea-AI Filing Summary

Allot Ltd. Senior Vice President of R&D, Boaz Grossman, reported an open-market sale of 5,000 ordinary shares at $7.37 per share. After this transaction, he directly holds 192,000 ordinary shares, indicating he retains a substantial equity position in the company.

Insights

Equity compensation and insider-trading analyst

Routine open-market sale of a small portion of existing holdings.

Senior Vice President of R&D Boaz Grossman executed an open-market sale of 5,000 ordinary shares of Allot Ltd. at $7.37 per share. This is classified as a non-derivative transaction with code S, indicating a straightforward sale.

Following the sale, Grossman directly holds 192,000 ordinary shares, so the transaction represents only a minor reduction in his stake. There are no derivative positions reported in this filing, and no footnotes indicating special arrangements or 10b5-1 trading plans.

The filing mainly updates Grossman’s ownership levels rather than signaling a major shift. Subsequent company filings may provide broader context on insider activity and any changes in overall executive ownership trends.

Insider Trade Summary

Net Seller: 5,000 shares

Net Sell 1 txn

Insider Grossman Boaz

Role Senior Vice President R&D

Sold 5,000 shs ($37K)

Type	Security	Shares	Price	Value
Sale	Ordinary shares	5,000	$7.37	$37K

Holdings After Transaction: Ordinary shares — 192,000 shares (Direct)

Key Figures

Shares sold: 5,000 shares Sale price: $7.37 per share Shares held after transaction: 192,000 shares +1 more

4 metrics

Shares sold 5,000 shares Open-market sale of ordinary shares

Sale price $7.37 per share Price for 5,000 ordinary shares sold

Shares held after transaction 192,000 shares Direct ownership after sale

Net shares sold 5,000 shares Net-sell direction per transactionSummary

Key Terms

open-market sale, ordinary shares, non-derivative, transaction code S

4 terms

open-market sale financial

"reported an open-market sale of 5,000 ordinary shares at $7.37 per share"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

ordinary shares financial

"open-market sale of 5,000 ordinary shares at $7.37 per share"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

non-derivative financial

"This is classified as a non-derivative transaction with code S"

transaction code S financial

"a non-derivative transaction with code S, indicating a straightforward sale"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Allot (ALLT) report for Boaz Grossman?

Allot reported that Senior Vice President of R&D Boaz Grossman sold 5,000 ordinary shares in an open-market transaction at $7.37 per share. The filing classifies this as a non-derivative sale under transaction code S for ordinary shares.

How many Allot (ALLT) shares does Boaz Grossman hold after the sale?

After the reported transaction, Boaz Grossman directly holds 192,000 ordinary shares of Allot. This figure comes from the Form 4’s “total shares following transaction” field and reflects his updated direct ownership stake post-sale.

Was Boaz Grossman’s Allot (ALLT) trade an open-market sale?

Yes. The Form 4 describes the transaction as an open-market sale of ordinary shares, coded S, at a price of $7.37 per share. This indicates Grossman sold shares directly into the market rather than through a derivative or private structure.

Does the Allot (ALLT) Form 4 show any derivative exercises by Boaz Grossman?

No derivative exercises are shown. The filing lists only a single non-derivative open-market sale of 5,000 ordinary shares. The derivativeSummary section is empty, indicating no options, warrants, or other derivatives were exercised or reported in this particular Form 4.

How large is Boaz Grossman’s Allot (ALLT) sale compared to his remaining stake?

Grossman sold 5,000 ordinary shares and now directly holds 192,000 shares. This means he disposed of only a small portion of his position, with the majority of his equity exposure to Allot remaining intact after the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 11:10 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Grossman Boaz

(Last) (First) (Middle)

22 HANAGAR STREET

INDUSTRIAL ZONE B

(Street)

HOD HASHARON 4501317

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Allot Ltd. [ ALLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior Vice President R&D

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary shares	05/20/2026		S		5,000	D	$7.37	192,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Boaz Grossman by: Oppenheimer Israel, as Attorney-in-fact	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)